Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.36EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BE.1.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.23EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.44EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-1649.2South Korea
BA.2.75EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5 (Omicron)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.3.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2 (Omicron)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used